A recent randomized controlled trial showed the limitations of either option, despite being a cornerstone of care.
Hassieb Din, MD
Advertisement
Articles by Hassieb Din, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
EADV Congress 2026: Day 2 Recap—6 Headlines to Know
2
No Signal for Birth Defects in Dupilumab Pregnancy Registry, With Tina Chambers, PhD, MPH
3
First-in-Class Oral ENV-294 Evaluated in Atopic Dermatitis, With Leon Kircik, MD
4
Nemolizumab Safety, Real-World Use in AD, With Matthias Augustin, MD
5